Panasonic Holdings Corporation
Panasonic Holdings Corporation (PCRFF) Stock Competitors & Peer Comparison
See (PCRFF) competitors and their performances in Stock Market.
Peer Comparison Table: Consumer Electronics Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRFF | $15.45 | -5.21% | 36.1B | 17.76 | $0.87 | +2.07% |
| SSNLF | $65.21 | +0.00% | 843.1B | 19.52 | $3.34 | +1.80% |
| SNEJF | $20.89 | -8.05% | 134.3B | 17.18 | $1.31 | +0.67% |
| XIACF | $4.38 | +1.86% | 116.3B | 21.38 | $0.21 | N/A |
| XIACY | $21.30 | +0.00% | 111B | 20.42 | $1.04 | N/A |
| KYOCF | $16.25 | -7.14% | 21.9B | 81.25 | $0.20 | +2.06% |
| PCRFY | $9.36 | -1.27% | 21.8B | 6.59 | $1.42 | N/A |
| KYOCY | $15.76 | -1.13% | 21.2B | 82.63 | $0.19 | +2.15% |
| TCLHF | $1.55 | +0.00% | 3.9B | 14.09 | $0.11 | +2.61% |
| SHCAF | $4.40 | +0.00% | 2.9B | 7.72 | $0.57 | N/A |
Stock Comparison
PCRFF vs SSNLF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SSNLF has a market cap of 843.1B. Regarding current trading prices, PCRFF is priced at $15.45, while SSNLF trades at $65.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SSNLF's P/E ratio is 19.52. In terms of profitability, PCRFF's ROE is +0.04%, compared to SSNLF's ROE of +0.11%. Regarding short-term risk, PCRFF is less volatile compared to SSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SSNLF's competition here
PCRFF vs SNEJF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SNEJF has a market cap of 134.3B. Regarding current trading prices, PCRFF is priced at $15.45, while SNEJF trades at $20.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SNEJF's P/E ratio is 17.18. In terms of profitability, PCRFF's ROE is +0.04%, compared to SNEJF's ROE of -0.03%. Regarding short-term risk, PCRFF is less volatile compared to SNEJF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SNEJF's competition here
PCRFF vs XIACF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, XIACF has a market cap of 116.3B. Regarding current trading prices, PCRFF is priced at $15.45, while XIACF trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas XIACF's P/E ratio is 21.38. In terms of profitability, PCRFF's ROE is +0.04%, compared to XIACF's ROE of +0.19%. Regarding short-term risk, PCRFF is less volatile compared to XIACF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check XIACF's competition here
PCRFF vs XIACY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, XIACY has a market cap of 111B. Regarding current trading prices, PCRFF is priced at $15.45, while XIACY trades at $21.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas XIACY's P/E ratio is 20.42. In terms of profitability, PCRFF's ROE is +0.04%, compared to XIACY's ROE of +0.19%. Regarding short-term risk, PCRFF is less volatile compared to XIACY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check XIACY's competition here
PCRFF vs KYOCF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, KYOCF has a market cap of 21.9B. Regarding current trading prices, PCRFF is priced at $15.45, while KYOCF trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas KYOCF's P/E ratio is 81.25. In terms of profitability, PCRFF's ROE is +0.04%, compared to KYOCF's ROE of +0.04%. Regarding short-term risk, PCRFF is less volatile compared to KYOCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check KYOCF's competition here
PCRFF vs PCRFY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, PCRFY has a market cap of 21.8B. Regarding current trading prices, PCRFF is priced at $15.45, while PCRFY trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas PCRFY's P/E ratio is 6.59. In terms of profitability, PCRFF's ROE is +0.04%, compared to PCRFY's ROE of +0.11%. Regarding short-term risk, PCRFF is less volatile compared to PCRFY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check PCRFY's competition here
PCRFF vs KYOCY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, KYOCY has a market cap of 21.2B. Regarding current trading prices, PCRFF is priced at $15.45, while KYOCY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas KYOCY's P/E ratio is 82.63. In terms of profitability, PCRFF's ROE is +0.04%, compared to KYOCY's ROE of +0.04%. Regarding short-term risk, PCRFF is less volatile compared to KYOCY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check KYOCY's competition here
PCRFF vs TCLHF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, TCLHF has a market cap of 3.9B. Regarding current trading prices, PCRFF is priced at $15.45, while TCLHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas TCLHF's P/E ratio is 14.09. In terms of profitability, PCRFF's ROE is +0.04%, compared to TCLHF's ROE of +0.13%. Regarding short-term risk, PCRFF and TCLHF have similar daily volatility (0.00).Check TCLHF's competition here
PCRFF vs SHCAF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SHCAF has a market cap of 2.9B. Regarding current trading prices, PCRFF is priced at $15.45, while SHCAF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SHCAF's P/E ratio is 7.72. In terms of profitability, PCRFF's ROE is +0.04%, compared to SHCAF's ROE of +0.54%. Regarding short-term risk, PCRFF and SHCAF have similar daily volatility (0.00).Check SHCAF's competition here
PCRFF vs SHCAY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SHCAY has a market cap of 2.4B. Regarding current trading prices, PCRFF is priced at $15.45, while SHCAY trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SHCAY's P/E ratio is 6.61. In terms of profitability, PCRFF's ROE is +0.04%, compared to SHCAY's ROE of +0.54%. Regarding short-term risk, PCRFF is less volatile compared to SHCAY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SHCAY's competition here
PCRFF vs CSIOF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, CSIOF has a market cap of 2.3B. Regarding current trading prices, PCRFF is priced at $15.45, while CSIOF trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas CSIOF's P/E ratio is 45.68. In terms of profitability, PCRFF's ROE is +0.04%, compared to CSIOF's ROE of +0.09%. Regarding short-term risk, PCRFF is less volatile compared to CSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CSIOF's competition here
PCRFF vs CSIOY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, CSIOY has a market cap of 2B. Regarding current trading prices, PCRFF is priced at $15.45, while CSIOY trades at $89.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas CSIOY's P/E ratio is 40.06. In terms of profitability, PCRFF's ROE is +0.04%, compared to CSIOY's ROE of +0.09%. Regarding short-term risk, PCRFF is less volatile compared to CSIOY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CSIOY's competition here
PCRFF vs AITUY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, AITUY has a market cap of 1.8B. Regarding current trading prices, PCRFF is priced at $15.45, while AITUY trades at $13.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas AITUY's P/E ratio is 25.87. In terms of profitability, PCRFF's ROE is +0.04%, compared to AITUY's ROE of +0.09%. Regarding short-term risk, PCRFF is less volatile compared to AITUY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check AITUY's competition here
PCRFF vs SNCPF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SNCPF has a market cap of 1.2B. Regarding current trading prices, PCRFF is priced at $15.45, while SNCPF trades at $54.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SNCPF's P/E ratio is 8.89. In terms of profitability, PCRFF's ROE is +0.04%, compared to SNCPF's ROE of +0.33%. Regarding short-term risk, PCRFF is less volatile compared to SNCPF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SNCPF's competition here
PCRFF vs JVCZY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, JVCZY has a market cap of 1.2B. Regarding current trading prices, PCRFF is priced at $15.45, while JVCZY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas JVCZY's P/E ratio is 11.52. In terms of profitability, PCRFF's ROE is +0.04%, compared to JVCZY's ROE of +0.14%. Regarding short-term risk, PCRFF and JVCZY have similar daily volatility (0.00).Check JVCZY's competition here
PCRFF vs SWDHF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SWDHF has a market cap of 983.6M. Regarding current trading prices, PCRFF is priced at $15.45, while SWDHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SWDHF's P/E ratio is 26.00. In terms of profitability, PCRFF's ROE is +0.04%, compared to SWDHF's ROE of +0.01%. Regarding short-term risk, PCRFF and SWDHF have similar daily volatility (0.00).Check SWDHF's competition here
PCRFF vs SWDHY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, SWDHY has a market cap of 779.6M. Regarding current trading prices, PCRFF is priced at $15.45, while SWDHY trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas SWDHY's P/E ratio is 20.68. In terms of profitability, PCRFF's ROE is +0.04%, compared to SWDHY's ROE of +0.01%. Regarding short-term risk, PCRFF is less volatile compared to SWDHY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SWDHY's competition here
PCRFF vs BGOUF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, BGOUF has a market cap of 224.7M. Regarding current trading prices, PCRFF is priced at $15.45, while BGOUF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas BGOUF's P/E ratio is -14.27. In terms of profitability, PCRFF's ROE is +0.04%, compared to BGOUF's ROE of -0.06%. Regarding short-term risk, PCRFF is less volatile compared to BGOUF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check BGOUF's competition here
PCRFF vs ADPXY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, ADPXY has a market cap of 119.2M. Regarding current trading prices, PCRFF is priced at $15.45, while ADPXY trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas ADPXY's P/E ratio is -11.10. In terms of profitability, PCRFF's ROE is +0.04%, compared to ADPXY's ROE of +0.83%. Regarding short-term risk, PCRFF is less volatile compared to ADPXY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check ADPXY's competition here
PCRFF vs DBOXF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, DBOXF has a market cap of 111.8M. Regarding current trading prices, PCRFF is priced at $15.45, while DBOXF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas DBOXF's P/E ratio is 10.04. In terms of profitability, PCRFF's ROE is +0.04%, compared to DBOXF's ROE of +0.71%. Regarding short-term risk, PCRFF is less volatile compared to DBOXF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check DBOXF's competition here
PCRFF vs CHWTF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, CHWTF has a market cap of 47.9M. Regarding current trading prices, PCRFF is priced at $15.45, while CHWTF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas CHWTF's P/E ratio is -1.48. In terms of profitability, PCRFF's ROE is +0.04%, compared to CHWTF's ROE of -0.14%. Regarding short-term risk, PCRFF is less volatile compared to CHWTF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CHWTF's competition here
PCRFF vs HLOC Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, HLOC has a market cap of 39.1M. Regarding current trading prices, PCRFF is priced at $15.45, while HLOC trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas HLOC's P/E ratio is -11.25. In terms of profitability, PCRFF's ROE is +0.04%, compared to HLOC's ROE of +0.60%. Regarding short-term risk, PCRFF and HLOC have similar daily volatility (0.00).Check HLOC's competition here
PCRFF vs HAPBF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, HAPBF has a market cap of 9.7M. Regarding current trading prices, PCRFF is priced at $15.45, while HAPBF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas HAPBF's P/E ratio is -2.15. In terms of profitability, PCRFF's ROE is +0.04%, compared to HAPBF's ROE of +0.55%. Regarding short-term risk, PCRFF is less volatile compared to HAPBF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check HAPBF's competition here
PCRFF vs VTEPF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, VTEPF has a market cap of 3.1M. Regarding current trading prices, PCRFF is priced at $15.45, while VTEPF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas VTEPF's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.04%, compared to VTEPF's ROE of -2.12%. Regarding short-term risk, PCRFF is less volatile compared to VTEPF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check VTEPF's competition here
PCRFF vs AMOSF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, AMOSF has a market cap of 120.9K. Regarding current trading prices, PCRFF is priced at $15.45, while AMOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas AMOSF's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.04%, compared to AMOSF's ROE of +1.10%. Regarding short-term risk, PCRFF and AMOSF have similar daily volatility (0.00).Check AMOSF's competition here
PCRFF vs NUHRF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, NUHRF has a market cap of 54.1K. Regarding current trading prices, PCRFF is priced at $15.45, while NUHRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas NUHRF's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to NUHRF's ROE of -3.48%. Regarding short-term risk, PCRFF is less volatile compared to NUHRF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NUHRF's competition here
PCRFF vs GAXY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, GAXY has a market cap of 23.3K. Regarding current trading prices, PCRFF is priced at $15.45, while GAXY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas GAXY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.04%, compared to GAXY's ROE of +4.24%. Regarding short-term risk, PCRFF and GAXY have similar daily volatility (0.00).Check GAXY's competition here
PCRFF vs COLCF Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, COLCF has a market cap of 8.3K. Regarding current trading prices, PCRFF is priced at $15.45, while COLCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas COLCF's P/E ratio is -0.04. In terms of profitability, PCRFF's ROE is +0.04%, compared to COLCF's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to COLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check COLCF's competition here
PCRFF vs ANDR Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, ANDR has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $15.45, while ANDR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas ANDR's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.04%, compared to ANDR's ROE of +0.13%. Regarding short-term risk, PCRFF and ANDR have similar daily volatility (0.00).Check ANDR's competition here
PCRFF vs BZIC Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, BZIC has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $15.45, while BZIC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas BZIC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.04%, compared to BZIC's ROE of +1.77%. Regarding short-term risk, PCRFF and BZIC have similar daily volatility (0.00).Check BZIC's competition here
PCRFF vs NGEY Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, NGEY has a market cap of 5.7K. Regarding current trading prices, PCRFF is priced at $15.45, while NGEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas NGEY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.04%, compared to NGEY's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to NGEY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NGEY's competition here
PCRFF vs CTXV Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, CTXV has a market cap of 2.5K. Regarding current trading prices, PCRFF is priced at $15.45, while CTXV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas CTXV's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to CTXV's ROE of +0.68%. Regarding short-term risk, PCRFF is less volatile compared to CTXV. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CTXV's competition here
PCRFF vs PUMD Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, PUMD has a market cap of 1.9K. Regarding current trading prices, PCRFF is priced at $15.45, while PUMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas PUMD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to PUMD's ROE of +0.90%. Regarding short-term risk, PCRFF is less volatile compared to PUMD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check PUMD's competition here
PCRFF vs GAXYQ Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, GAXYQ has a market cap of 1.2K. Regarding current trading prices, PCRFF is priced at $15.45, while GAXYQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas GAXYQ's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.04%, compared to GAXYQ's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to GAXYQ. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check GAXYQ's competition here
PCRFF vs ZVTK Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, ZVTK has a market cap of 704. Regarding current trading prices, PCRFF is priced at $15.45, while ZVTK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas ZVTK's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to ZVTK's ROE of +0.02%. Regarding short-term risk, PCRFF is less volatile compared to ZVTK. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check ZVTK's competition here
PCRFF vs LTEC Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, LTEC has a market cap of 486. Regarding current trading prices, PCRFF is priced at $15.45, while LTEC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas LTEC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.04%, compared to LTEC's ROE of -2.97%. Regarding short-term risk, PCRFF and LTEC have similar daily volatility (0.00).Check LTEC's competition here
PCRFF vs CYRD Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, CYRD has a market cap of 348. Regarding current trading prices, PCRFF is priced at $15.45, while CYRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas CYRD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to CYRD's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to CYRD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CYRD's competition here
PCRFF vs NYXO Comparison March 2026
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 36.1B. In comparison, NYXO has a market cap of 242. Regarding current trading prices, PCRFF is priced at $15.45, while NYXO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 17.76, whereas NYXO's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.04%, compared to NYXO's ROE of +5.00%. Regarding short-term risk, PCRFF is less volatile compared to NYXO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NYXO's competition here